Latest News

 Filter by Provider

This morning had the potential to be another nasty one.

Shares of Merck & Company are trading higher the FDA approved pembrolizumab with enfortumab vedotin-ejfv for muscle-invasive bladder cancer.

Elastic crushed earnings expectations but the stock crashed anyway.

Pfizer rises after a study found that the company's new mRNA flu vaccine outperforms traditional shots against predominant strains.

Curious about the S&P500 stocks that are in motion on Friday? Join us as we explore the top movers within the S&P500 index during today's session.

The USD Index looks ripe for a major rally. The USD Index futures closed above 100 for the second day yesterday, and it seems that they are going to do the same thing also today.

The company feels like it's in a right time/right place situation these days.

Michigan November final almost as low at June 2025.

Ford Motor shares are trading higher due to a dual tailwind of reassured operational stability and shifting monetary policy expectations.

Stay up-to-date with the latest market trends one hour before the close of the markets on Friday. Explore the top gainers and losers during today's session in our detailed report.

The Dow Jones recovered over 700 points on Friday as equities recover their footing.

The S&P 500 index is trading back below its 50 day moving average after a massive downside reversal day yesterday.

Kalshi's valuation jumps to $11B after a reported $1B raise as trading volume surges sixfold and regulatory wins accelerate its lead in U.S. prediction markets.

Strategy's digital asset treasury company model is facing its first major crisis and arguably, an existential one.

The Vanguard Mega Cap Growth ETF has outpaced the Vanguard S&P 500 ETF in 1-year and 5-year total returns but carries a higher expense ratio and greater sector concentration.

Eli Lilly and Co (NYSE:LLY) shares are trading higher on Friday. The company plans to start selling its obesity drug through a new approach aimed at expanding access.

The company raised fears of shareholder dilution.

Bitcoin clawed back some of its steep weekly losses, reclaiming the $84,000 level despite elevated liquidations and a market still gripped by extreme fear.

Amazon cuts thousands of jobs while investing in AI, resulting in layoffs for engineers. CEO prioritizes AI adoption to replace repetitive roles.

March NY world sugar #11 (SBH26 ) on Friday closed up +12 (+0.82%), and March London ICE white sugar #5 (SWH26 ) closed up +4.10 (+0.98%). Sugar prices recovered from early losses on Friday and settled higher on some pre-weekend short covering. Sinc...

March ICE NY cocoa (CCH26 ) on Friday closed down -123 (-2.33%), and December ICE London cocoa #7 (CAZ25 ) closed down -97 (-2.50%). Cocoa prices settled sharply lower on Friday, with London cocoa falling to a 1.75-year low on the nearest-futures cha...

If you think slow and steady wins the race, then this cryptocurrency is probably not for you.

Direxion has rolled out five new single-stock ETFs offering amplified exposure to crypto platforms and AI infrastructure, with leveraged bets.

March arabica coffee (KCH26 ) on Friday closed down -7.20 (-1.91%), and January ICE robusta coffee (RMF26 ) closed down -125 (-2.70%). Coffee prices fell sharply on Friday, with arabica posting a 7-week low. Coffee prices tumbled on Friday after Pr...

Nvidia stock tried to find its footing Friday after bears mauled names tied to the artificial intelligence megatrend.

Gold surges towards $4,100 after Fed officials signal openness to a December rate cut, boosting dovish bets.

BitMine Immersion Inc.

Meta is testing a new AI-powered briefing for Facebook users to compete with ChatGPT's Pulse. Meta faces AI spending concerns.

Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Friday and discover the stocks that are dominating the trading activity and setting the pace for the market.

Plug Power shares rose after a major refinancing cut high-cost debt, extended low-cost funding and set up a key share-authorization vote.

CyberArk shareholders have approved a takeover offer from Palo Alto Networks.

These stocks are making the most noise in today's session. Stay tuned for the latest updates!

CNSide Diagnostics, a Plus Therapeutics subsidiary, secured a national agreement with Humana to provide its CNSide CSF Tumor Cell Enumeration test, expanding coverage to 67 million people.

The U.S. labor market presented a perplexing and pivotal report in September 2025, revealing a stronger-than-expected nonfarm payroll gain that nonetheless coincided with an unwelcome rise in the unemployment rate. This intricate data tapestry, unveiled amidst the backdrop of a significant government shutdown and subsequent data delays, has intensified